Thromboprophylaxis and neuraxial anesthesia

Orthopedics

Volumn 26, Issue 2 SUPPL., 2003, Pages

  Horlocker, Terese T ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CELECOXIB; CLOPIDOGREL; DALTEPARIN; ENOXAPARIN; HEPARIN; IBUPROFEN; KETOROLAC; LOW MOLECULAR WEIGHT HEPARIN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; ROFECOXIB; TICLOPIDINE; TINZAPARIN; WARFARIN;

ANALGESIA; ANTICOAGULANT THERAPY; ARTICLE; BACKACHE; BLADDER DYSFUNCTION; BLEEDING; CATHETERIZATION; DEVICE REMOVAL; DISEASE SEVERITY; DRUG HALF LIFE; DRUG LABELING; DRUG MECHANISM; ENTEROPATHY; EPIDURAL ANESTHESIA; HUMAN; INDWELLING CATHETER; MUSCLE WEAKNESS; PARESTHESIA; PATIENT MONITORING; RISK FACTOR; SPINAL ANESTHESIA; SPINAL CORD COMPRESSION; SPINAL CORD HEMORRHAGE; SPINAL CORD ISCHEMIA; SPINE RADIOGRAPHY; THROMBOEMBOLISM; THROMBOSIS PREVENTION;

ANESTHESIA, EPIDURAL; ANESTHESIA, SPINAL; ARTHROSCOPY; FIBRINOLYTIC AGENTS; HEMATOMA, EPIDURAL, CRANIAL; HEMATOMA, SUBDURAL; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; THROMBOSIS; TIME FACTORS;

EID: 0037322374     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Liu S, Carpenter RL, Neal JM. Epidural anesthesia and analgesia. Their role in postoperative outcome. Anesthesiology. 1995; 82: 174-1506.
2. Modig J. The role of lumbar epidural anaesthesia as antithrombotic prophylaxis in total hip replacement. Acta Chirurgica Scand. 1985; 151: 589-594.
3. Geerts WH, Heit JA, Clagett GP, et al. Prevention of venous thromboembolism. [Review] Chest. 2001; 119: 132S-175S.
4. Capdevilla X, Barthelet Y, Biboulet P, et al. Effects of perioperative analgesic technique on the surgical outcome and duration of rehabilitation after major knee surgery. Anesthesiology. 1999; 91: 8-15.
5. Tryba M. Rückmarksnahe regionalanästhesie und niedermolekulare heparine. Pro Anästh Intensivmed Notfallmed Schmerzther. 1993; 28: 179-181.
6. Vandermeulen EP, Van Aken H, Vermylen J. Anticoagulants and spinal-epidural anesthesia. Anesth Analg 1994; 79: 1165-77.
7. Cheney FW, Domino KB, Caplan RA, Posner KL. Nerve injury associated with anesthesia: a closed claims analysis. Anesthesiology. 1999; 90: 1062-1069.
8. Horlocker TT, Wedel DJ. Neuraxial block and low molecular weight heparin: balancing perioperative analgesia and thromboprophylaxis. Reg Anesth Pain Med. 1998; 23: 164-177.
9. Tryba M. European practice guidelines: thromboembolism prophylaxis and regional anesthesia. Reg Anesth Pain Med. 1998; 23: 178-182.
10. Bergqvist D, Lindblad B, Matzsch T. Risk of combining low molecular weight heparin for thromboprophylaxis and epidural or spinal anesthesia. Semin Thromb Hemost. 1993; 19: 147-151.
11. Schroeder DR. Statistics: detecting a rare adverse drug reaction using spontaneous reports. Reg Anesth Pain Med. 1998; 23: 183-189.
12. Rodriguez-Arias CA, Martinez R, MacVeigh I, Taboada M. Epidural lumbar hematoma, epidural anesthesia and low-molecular-weight heparins. [Spanish] Neurocirugia. 2001; 12: 509-512.
13. Litz RJ, Hubler M, Koch T, Albrecht M. Spinal-epidural hematoma following epidural anesthesia in the presence of antiplatelet and heparin therapy. Anesthesiology. 2001; 95: 1031-1033.
14. Hull RD, Pineo GF, Francis C, et al. Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients: a double-blind, randomized comparison. The North American Fragmin Trial Investigators. Arch Int Med. 2000; 160: 2199-2207.
15. Heit JA. Perioperative management of the chronically anticoagulated patient. [Review] J Thrombosis Thrombolysis. 2001; 12: 81-87.
16. McEvoy MD, Bailey M, Taylor D, Del Schutte H. Noncompliance in the inpatient administration of enoxaparin in conjuction with epidural or spinal anesthesia. J Arthroplasty. 2000; 15: 604-607.
17. Majerus PW, Broze GJ, Miletich JP, Tollefsen DM. Anticoagulant, thrombolytic, and antiplatelet drugs. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AJ, eds. Pharmacologic Basis of Therapeutics. 9th ed. New York: Macmillan Publishing Co; 1990; 1341-1359.
18. Xi M, Beguin S, Hemker HC. The relative importance of the Factors II, VII, IX and X for the prothrombinase activity in plasma of orally anticoagulated patients. Thromb Haemost. 1989; 62: 788-791.
19. Harder S, Thurmann P. Clinically important drug interactions with anticoagulants: an update. Clin Pharmacokinet. 1996; 30: 416-444.
20. Odoom JA, Sih IL. Epidural analgesia and anticoagulant therapy: experience with one thousand cases of continuous epidurals. Anaesthesia. 1983; 38: 254-259.
21. Horlocker TT, Wedel DJ, Schlicting JL. Postoperative epidural analgesia and oral anticoagulant therapy. Anesth Analg. 1994; 79: 89-93.
22. Wu CL, Perkins FM. Oral anticoagulant prophylaxis and epidural catheter removal. Reg Anesth. 1996; 21: 517-524.
23. Woolson ST, Robinson RK, Khan NQ, et al. Deep venous thrombosis prophylaxis for knee replacement: warfarin and pneumatic compression. Am J Orthop. 1998; 27: 299-304.
24. Badenhorst CH. Epidural hematoma after epidural pain control and concomitant postoperative anticoagulation. Reg Anesth. 1996; 21: 272-273.
25. Enneking KF, Benzon HT. Oral anticoagulants and regional anesthesia: a perspective. Reg Anesth Pain Med. 1998; 23: 140-145.
26. Cronberg S, Wallmark E, Soderberg I. Effect on platelet aggregation of oral administration of 10 non-steroidal analgesics to humans. Scand J Haematol. 1984; 33: 155-159.
27. Rodgers RPC, Levin J. A critical reappraisal of the bleeding time. Semin Thromb Hemost. 1990; 16: 1-20.
28. Leese PT, Hubbard RC, Karim A, et al. Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy aduts: a randomized, controlled trial. J Clin Pharmacol. 2000; 40: 124-132.
29. Cannon GW, Caldwell JR, Holt P, et al. Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip. Rofecoxib Phase III Protocol 035 Study Group. Arthritis Rheum. 2000; 43: 978-987.
30. Coukell AJ. Clopidogret. Drugs. 1997; 54: 745-750.
31. Taniuchi M, Kurz HI, Lasala JM. Randomized comparison of ticlopidine and clopidogrel after intracoronary stent implantation in a broad patient population. Circulation. 2001; 104: 539-543.
32. Kovesi T, Royston D. Is there a bleeding problem with platelet-active drugs? [Editorial] Br J Anaesth 2002; 88: 159-163.
33. Benzon HT, Wong HY, Siddiqui T, Ondra S. Caution in performing epidural injections in patients on several antiplatelet drugs. Anesthesiology. 1999; 91: 1558-1559.
34. Horlocker TT, Wedel DJ, Schroeder DR, et al. Preoperative antiplatelet therapy does not increase the risk of spinal hematoma with regional anesthesia. Anesth Analg. 1995; 80: 303-309.
35. CLASP (Collaborative Low-Dose Aspirin Study in Pregnancy) Collaborative Group. CLASP: a randomized trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet. 1994; 343: 619-629.
36. Horlocker TT, Bajwa ZH, Ashraft Z, et al. Risk assessment of hemorrhagic complications associated with nonsteroidal antiiflammatory medications in ambulatory pain clinic patients undergoing epidural steroid injection. Anesth Analg. 2002; 95.